Skip to content

Clinical trials

Stroke trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Stroke Country / region: Russia Clear all

97 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20034
20041
20053
20062
20071
20081
20094
20101
20115
20126
201312
20143
20158
20161
20184
20196
20215
20225
20237
20247
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed58
Recruiting15
Unknown status11
Terminated10
Not yet recruiting1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bayer6
Federal Center of Cerebrovascular Pathology and Stroke, Russian Federation Ministry of Health6
Boehringer Ingelheim5
Pharmasoft5
AstraZeneca4
Clinical Institute of the Brain, Russia3
Novartis Pharmaceuticals3
POLYSAN Scientific & Technological Pharmaceutical Company3
Skolkovo Institute of Science and Technology3
Allergan2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Stroke97
Atrial Fibrillation17
Ischemic Stroke17
Myocardial Infarction14
Cardiovascular Diseases9
Ischemic Attack, Transient7
Embolism6
Muscle Spasticity6
Thromboembolism6
Atherosclerosis5

Trials

Showing 76 to 97 of 97. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.